BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 90 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $2,492,000 | +0.4% | 41,737 | +4.8% | 0.00% | -33.3% |
| Q1 2019 | $2,483,000 | +2.5% | 39,842 | -0.3% | 0.00% | 0.0% |
| Q4 2018 | $2,422,000 | +356.1% | 39,967 | +340.5% | 0.00% | +200.0% |
| Q3 2018 | $531,000 | +17.2% | 9,073 | -10.2% | 0.00% | – |
| Q2 2018 | $453,000 | -8.9% | 10,105 | -9.9% | 0.00% | -100.0% |
| Q1 2018 | $497,000 | +0.2% | 11,220 | -2.1% | 0.00% | – |
| Q4 2017 | $496,000 | -58.4% | 11,455 | -55.3% | 0.00% | -100.0% |
| Q3 2017 | $1,191,000 | -21.0% | 25,607 | -15.9% | 0.00% | -50.0% |
| Q2 2017 | $1,508,000 | -8.8% | 30,461 | +1.0% | 0.00% | 0.0% |
| Q1 2017 | $1,653,000 | -9.5% | 30,159 | -8.1% | 0.00% | 0.0% |
| Q4 2016 | $1,827,000 | +14.0% | 32,803 | -6.5% | 0.00% | 0.0% |
| Q3 2016 | $1,603,000 | -28.8% | 35,100 | -37.7% | 0.00% | -33.3% |
| Q2 2016 | $2,250,000 | +82.8% | 56,335 | +59.3% | 0.00% | +200.0% |
| Q1 2016 | $1,231,000 | -14.2% | 35,356 | +5.9% | 0.00% | -50.0% |
| Q4 2015 | $1,434,000 | -0.4% | 33,380 | +0.9% | 0.00% | 0.0% |
| Q3 2015 | $1,440,000 | +8.6% | 33,073 | +28.7% | 0.00% | +100.0% |
| Q2 2015 | $1,326,000 | +32.5% | 25,706 | +0.5% | 0.00% | 0.0% |
| Q1 2015 | $1,001,000 | +31.0% | 25,575 | +29.3% | 0.00% | 0.0% |
| Q4 2014 | $764,000 | – | 19,778 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|